Angiotensin converting enzyme (ACE) inhibitors activity from purified compounds Fructus Phaleria macrocarpa (Scheff) Boerl
© 2023. The Author(s)..
BACKGROUND: Mahkota Dewa [Phaleria macrocarpa (Scheff) Boerl.] fruit in vitro and in- vivo can decrease and prevent elevation of the blood pressure, lower plasma glucose levels, possess an antioxidant effect, and recover liver and kidney damage in rats. This study aimed to determine the structure and inhibitory activity of angiotensin-converting enzyme inhibitors (ACE) from the Mahkota Dewa fruit.
METHODS: The fruit powder was macerated using methanol and then partitioned by hexane, ethyl acetate, n-butanol, and water. The fractions were chromatographed on the column chromatography and incorporated with TLC and recrystallization to give pure compounds. The structures of isolated compounds were determined by UV-Visible, FT-IR, MS, proton (1H-NMR), carbon (13C-NMR), and 2D-NMR techniques encompassing HMQC and HMBC spectra. The compounds were evaluated for their ACE inhibitory activity, and the strongest compound was determined by the kinetics enzyme inhibition.
RESULTS: Based on the spectral data, the isolated compounds were determined as 6,4-dihydroxy-4-methoxybenzophenone-2-O-β-D-glucopyranoside (1), 4,4'-dihydroxy-6-methoxybenzophenone-2-O-β-D-glucopyranoside (2) and mangiferin (3). IC50 values of the isolated compounds 1, 2 and 3 were 0.055, 0.07, and 0.025 mM, respectively.
CONCLUSION: The three compounds have ACE inhibitor and mangiferin demonstrated the best ACE inhibitory activity with competitive inhibition on ACE with the type of inhibition kinetics is competitive inhibition.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
BMC complementary medicine and therapies - 23(2023), 1 vom: 20. Feb., Seite 56 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Eff, Aprilita Rina Yanti [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 23.02.2023 Date Revised 24.02.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12906-023-03889-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM353099406 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM353099406 | ||
003 | DE-627 | ||
005 | 20231226055228.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12906-023-03889-x |2 doi | |
028 | 5 | 2 | |a pubmed24n1176.xml |
035 | |a (DE-627)NLM353099406 | ||
035 | |a (NLM)36803524 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Eff, Aprilita Rina Yanti |e verfasserin |4 aut | |
245 | 1 | 0 | |a Angiotensin converting enzyme (ACE) inhibitors activity from purified compounds Fructus Phaleria macrocarpa (Scheff) Boerl |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.02.2023 | ||
500 | |a Date Revised 24.02.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a BACKGROUND: Mahkota Dewa [Phaleria macrocarpa (Scheff) Boerl.] fruit in vitro and in- vivo can decrease and prevent elevation of the blood pressure, lower plasma glucose levels, possess an antioxidant effect, and recover liver and kidney damage in rats. This study aimed to determine the structure and inhibitory activity of angiotensin-converting enzyme inhibitors (ACE) from the Mahkota Dewa fruit | ||
520 | |a METHODS: The fruit powder was macerated using methanol and then partitioned by hexane, ethyl acetate, n-butanol, and water. The fractions were chromatographed on the column chromatography and incorporated with TLC and recrystallization to give pure compounds. The structures of isolated compounds were determined by UV-Visible, FT-IR, MS, proton (1H-NMR), carbon (13C-NMR), and 2D-NMR techniques encompassing HMQC and HMBC spectra. The compounds were evaluated for their ACE inhibitory activity, and the strongest compound was determined by the kinetics enzyme inhibition | ||
520 | |a RESULTS: Based on the spectral data, the isolated compounds were determined as 6,4-dihydroxy-4-methoxybenzophenone-2-O-β-D-glucopyranoside (1), 4,4'-dihydroxy-6-methoxybenzophenone-2-O-β-D-glucopyranoside (2) and mangiferin (3). IC50 values of the isolated compounds 1, 2 and 3 were 0.055, 0.07, and 0.025 mM, respectively | ||
520 | |a CONCLUSION: The three compounds have ACE inhibitor and mangiferin demonstrated the best ACE inhibitory activity with competitive inhibition on ACE with the type of inhibition kinetics is competitive inhibition | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a 4,4′-dihydroxy-6-methoxybenzophenone-2-O-β-D-glucopyranoside | |
650 | 4 | |a 6,4-dihydroxy-4-methoxybenzophenone–2-O-β-D-glucopyranoside | |
650 | 4 | |a ACE inhibitor | |
650 | 4 | |a Mangiferin | |
650 | 4 | |a Phaleria macrocarpa | |
650 | 7 | |a Angiotensin-Converting Enzyme Inhibitors |2 NLM | |
650 | 7 | |a Plant Extracts |2 NLM | |
700 | 1 | |a Huri, Hasniza Zaman |e verfasserin |4 aut | |
700 | 1 | |a Radji, Maksum |e verfasserin |4 aut | |
700 | 1 | |a Mun'im, Abdul |e verfasserin |4 aut | |
700 | 1 | |a Suyatna, F D |e verfasserin |4 aut | |
700 | 1 | |a Eden, Yonatan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC complementary medicine and therapies |d 2020 |g 23(2023), 1 vom: 20. Feb., Seite 56 |w (DE-627)NLM306156547 |x 2662-7671 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2023 |g number:1 |g day:20 |g month:02 |g pages:56 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12906-023-03889-x |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2023 |e 1 |b 20 |c 02 |h 56 |